Agios Pharmaceuticals, Inc. (AGIO)
29.19
-1.04
(-3.44%)
USD |
NASDAQ |
Mar 02, 16:00
29.19
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Research and Development Expense (Annual) : 334.36M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| CorMedix, Inc. | 3.942M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Enanta Pharmaceuticals, Inc. | 106.74M |
| Karyopharm Therapeutics, Inc. | 125.32M |